论文部分内容阅读
为探讨血清肿瘤标志物CY2 1 - 1、CEA、CA1 5 - 3、SCC单项检测及联合检测在肺癌诊断中的临床价值。对 87例经细胞学或组织病理学证实诊断为肺癌的住院患者入院时血清CY2 1 - 1、CEA、CA1 5 - 3及SCC检测结果进行了分析。结果表明 ,(1 )CY2 1 - 1、CEA、CA1 5 - 3及SCC单项检测对肺癌诊断的敏感度分别为 :5 9.8%、3 9.1 %、4 4.8%和 1 8.4 %。 (2 )联合检测对肺癌诊断的敏感度 :Ⅰ组 :CY2 1 - 1 +CEA为 78.2 % ,Ⅱ组 :CY2 1 - 1 +CEA +CA1 5 - 3为 88.5 % ,Ⅲ组 :CY2 1 - 1 +CEA +CA1 5 - 3 +SCC其诊断敏感度与Ⅱ组相同
To explore the clinical value of serum tumor markers CY21-1, CEA, CA15-5, SCC single detection and combined detection in the diagnosis of lung cancer. Eighty-eight hospitalized patients diagnosed with lung cancer by cytology or histopathology were analyzed for serum CY2-1, CEA, CA15-3, and SCC at admission. The results showed that (1) the sensitivity of CY21-1, CEA, CA15-5, and SCC single tests for the diagnosis of lung cancer were: 5 9.8%, 39.1%, 4 4.8%, and 18.4%. (2) Sensitivity of joint detection to the diagnosis of lung cancer: Group I: CY2 1 - 1 +CEA was 78.2%; Group II: CY2 1 - 1 +CEA +CA1 5 - 3 was 88.5 %; Group III: CY2 1 - 1 +CEA +CA1 5 - 3 +SCC has the same diagnostic sensitivity as Group II